Dilon’s MarginProbe® the Focus of Major Symposium at the 2011 German Forum for Operative Gynecology Meeting in Berlin

[vc_row][vc_column][vc_column_text] Dan Levangie Appointed as CEO ahead of FDA Approval and US Launch Framingham, MA (PRWEB) October 25, 2011 Dilon Devices, Inc. today announced that a major symposium was conducted at the German Forum for Operative Gynecology (FOG) meeting in Berlin. Attended by over 75 leaders in the field of breast cancer in Germany, the…

Read More